Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L32 pseudogene 30 (RPL32P30) is a *processed pseudogene* related to the ribosomal protein L32 gene. Pseudogenes are non-functional DNA sequences that originate from functional genes but usually lack regulatory elements needed for expression or encode nonfunctional/fragmented proteins[1][5][10]. RPL32P30 is part of a family of pseudogenes widely distributed in the genome, which means it does not encode a protein nor participate in ribosome structure or protein synthesis. While some pseudogenes—including other RPL32 pseudogenes—may have context-specific regulatory effects in cancer or development, no research has specifically implicated RPL32P30 in such functions, and it should not be treated as a therapeutic target or actionable molecule[2][5][10][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L32 pseudogene 30 (RPL32P30).